NO175487C - Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav - Google Patents

Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav

Info

Publication number
NO175487C
NO175487C NO852776A NO852776A NO175487C NO 175487 C NO175487 C NO 175487C NO 852776 A NO852776 A NO 852776A NO 852776 A NO852776 A NO 852776A NO 175487 C NO175487 C NO 175487C
Authority
NO
Norway
Prior art keywords
preparation
derivatives
human interferon
recombinant plasmids
amino acids
Prior art date
Application number
NO852776A
Other languages
English (en)
Norwegian (no)
Other versions
NO175487B (no
NO852776L (no
Inventor
Seiga Itoh
Yasutoshi Takeichi
Moriyuki Sato
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15350817&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO175487(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO852776L publication Critical patent/NO852776L/no
Publication of NO175487B publication Critical patent/NO175487B/no
Publication of NO175487C publication Critical patent/NO175487C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO852776A 1984-07-11 1985-07-10 Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav NO175487C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14395084A JPS6124599A (ja) 1984-07-11 1984-07-11 新規ヒトインタ−フエロン−ｒポリペプチド誘導体

Publications (3)

Publication Number Publication Date
NO852776L NO852776L (no) 1986-01-13
NO175487B NO175487B (no) 1994-07-11
NO175487C true NO175487C (no) 1994-10-19

Family

ID=15350817

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852776A NO175487C (no) 1984-07-11 1985-07-10 Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav

Country Status (11)

Country Link
US (1) US4898931A (da)
EP (1) EP0170917B1 (da)
JP (1) JPS6124599A (da)
AT (1) ATE63923T1 (da)
AU (1) AU586822B2 (da)
CA (1) CA1303529C (da)
DE (2) DE3582973D1 (da)
DK (1) DK164108C (da)
ES (1) ES8609484A1 (da)
IL (1) IL75738A (da)
NO (1) NO175487C (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334102D0 (en) * 1983-12-21 1984-02-01 Searle & Co Interferons with cysteine pattern
CA1340265C (en) * 1985-01-18 1998-12-15 Kirston E. Koths Oxidation resistant muteins
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
AT393690B (de) * 1987-10-08 1991-11-25 Hoffmann La Roche Homogene, rekombinante immun-interferonfragmente
DE3829180A1 (de) * 1988-08-29 1990-03-08 Boehringer Ingelheim Int Neues arzneimittel zur vorbeugung und behandlung von durch primaere immundefekte verursachte krankheiten
DE4036856C1 (da) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De
KR100475492B1 (ko) * 1995-01-26 2005-03-14 바이오겐 아이덱 엠에이 인코포레이티드 항종양제로서의 림프독소-α/β 복합체 및항-림프독소-β수용체 항체
DE19535853C2 (de) * 1995-09-18 1999-04-01 Fraunhofer Ges Forschung Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
AU782635B2 (en) * 1999-11-12 2005-08-18 Maxygen Holdings Ltd. Interferon gamma conjugates
CA2390292A1 (en) 1999-11-12 2001-05-25 Maxygen Holdings Ltd. Interferon gamma conjugates
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
CA2491178A1 (en) 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
BRPI0507169A (pt) * 2004-02-02 2007-06-26 Ambrx Inc polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
AU2006255122B2 (en) * 2005-06-03 2010-10-21 Ambrx, Inc. Improved human interferon molecules and their uses
EP1991679A2 (fr) * 2006-03-08 2008-11-19 Biomethodes Variants de l'interferon- gamma humain (ifngamma)
FR2898359B1 (fr) * 2006-03-08 2011-07-15 Biomethodes Variants ameliores de l'interferon-gamma humain (ifn gamma)
MX344166B (es) 2008-02-08 2016-12-07 Ambrx Inc Leptina-polipeptidos modificados y sus usos.
WO2020028275A1 (en) * 2018-07-30 2020-02-06 The Board Of Trustees Of The Leland Stanford Junior University Interferon-gamma biased agonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
IL69851A0 (en) * 1982-09-30 1983-12-30 Japan Found Cancer Novel dna and recombinant plasmid containing the same
US4758656A (en) * 1983-12-26 1988-07-19 Kyowa Hakko Kogyo Co., Ltd. Novel human interferon-gamma polypeptide derivative
AU582574B2 (en) * 1984-04-19 1989-04-06 Hoechst Aktiengesellschaft The preparation of polypeptides having human gamma interferon activity
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof

Also Published As

Publication number Publication date
US4898931A (en) 1990-02-06
DK314485A (da) 1986-01-12
ES8609484A1 (es) 1986-09-01
DK164108C (da) 1992-10-12
AU586822B2 (en) 1989-07-27
EP0170917B1 (en) 1991-05-29
JPS6124599A (ja) 1986-02-03
AU4474985A (en) 1986-01-16
EP0170917A1 (en) 1986-02-12
DK164108B (da) 1992-05-11
NO175487B (no) 1994-07-11
DE3582973D1 (de) 1991-07-04
IL75738A (en) 1995-06-29
IL75738A0 (en) 1985-11-29
ES545052A0 (es) 1986-09-01
ATE63923T1 (de) 1991-06-15
NO852776L (no) 1986-01-13
CA1303529C (en) 1992-06-16
DK314485D0 (da) 1985-07-10
DE170917T1 (de) 1986-09-04

Similar Documents

Publication Publication Date Title
NO175487C (no) Rekombinante plasmider for bruk ved fremstilling av derivat av humant interferon--polypeptid samt fremgangsmåte for fremstilling derav
FI882176A7 (fi) Menetelmä terapeuttisesti aktiivisten heterosyklisten peptidien valmistamiseksi ja niiden valmistuksessa käyttökelpoisia välituotteita
NO164177C (no) Rekombinant dna-fremgangsmaate for fremstilling av et polypeptid med funksjon av human immun (gamma)-interferon.
EP0201743A3 (en) Dipeptide derivatives of fatty acids, process for preparing them, pharmaceutical composition and use
EP0243929A3 (en) Polypeptide and protein derivatives and process for their preparation
GB2037296B (en) Purified proteins expecially interferon and process therefor
NZ192991A (en) Preparation of purified protein hydrolysate
DE3873397D1 (de) Bifunktionelle proteine.
IL61058A0 (en) Derivatives of amino acids and process for their preparation
NZ209590A (en) Gamma interferon analogue, preparation and pharmaceutical composition
FI891123A7 (fi) Menetelmä 1-syklopropyylikinolonikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
FI891122A7 (fi) N-syklopropyylianiliinit ja niiden käyttö menetelmässä 1-syklopropyylikinolonikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
AU2421588A (en) Procaryotic xylose isomerase muteins and method to increase protein stability
YU146686A (en) Process for preparing derivatives of amino acids
ZA869460B (en) Oxygenated-alkyl derivatives of glumatic and aspartic acids with antagonistic activity to bio-active polypeptides and a method for their preparation
FI102282B1 (fi) Menetelmä O-glykosyloidun IGF-1:n valmistamiseksi
EP0448605A4 (en) Use of basic amino acids to solubilize immunoglobulins
ES2078229T3 (es) Procedimiento para la preparacion de un polipeptido similar a la motilina y su expresion.
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
AU3328289A (en) Expression of hepatitis B2 pres protein in methylothrophic yeasts
FI861931A7 (fi) Menetelmä 6-(alempi)alkoksi-1-naftoehappojen ja vastaavien estereiden valmistamiseksi ja tämän menetelmän käyttö valmistettaessa 6-(alempi) alkoksi-5-halo-1-naftoehappoja ja vastaavia estereitä.
NZ235774A (en) Peptide with amino acid sequence homologous to portion of porcine somatotropin; antibodies and their use in potentiating the activity of pst
FI892254A7 (fi) a-aminoboronihappojohdannaisten käyttö peptidi- ja proteiinilääkeaineiden stabiloimiseen
IT7951108A0 (it) Procedimento per la preparazione di cloridrati di amminoacidi e biclori drati di diamminoacidi
FI892323A7 (fi) Menetelmä 5-amino-7(substituoitu amino)-kinoliini-3-karboksyyli-happojen valmistamiseksi